Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
6.03
+0.16 (2.73%)
Apr 8, 2026, 11:05 AM EDT - Market open
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $1.04 billion as of April 8, 2026. Its market cap has increased by 16.25% in one year.
Market Cap
1.04B
Enterprise Value
1.16B
1-Year Change
16.25%
Ranking
Category
Stock Price
$6.03
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $1.04B, an increase of 251.54%. That is a compound annual growth rate of 32.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 1.01B | -22.29% |
| Dec 31, 2025 | 1.30B | 157.72% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
| Oct 6, 2021 | 295.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geron | 1.11B |
| ArriVent BioPharma | 1.11B |
| uniQure | 1.07B |
| MapLight Therapeutics | 1.06B |
| KalVista Pharmaceuticals | 1.03B |
| Inventiva | 1.01B |
| AbCellera Biologics | 1.00B |
| Annexon | 961.24M |